Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aileen G Rowan

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Blood|April 24, 2020
CD28 fusions: an opportunity for young ATL?Lucy B M Cook, Aileen G Rowan
Leukemia Research and Treatment|December 22, 2012
Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?Aileen G Rowan, Charles R M Bangham
Leukemia Research|December 6, 2024
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)Devon A Weterings, Aileen G Rowan, Lucy B Cook
Virology|December 11, 2012
HTLV-1: persistence and pathogenesisLucy B Cook, Marjet Elemans, Aileen G Rowan, et al.
Blood|February 9, 2011
The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signalsAndrea K Kress, Martina Kalmer, Aileen G Rowan, et al.
European Journal of Immunology|November 25, 2003
Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytesMiriam T Brady, Angus J MacDonald, Aileen G Rowan, et al.
Plos Pathogens|April 23, 2016
CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated LysisKiruthika Manivannan, Aileen G Rowan, Yuetsu Tanaka, et al.
Frontiers in Immunology|April 28, 2023
Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?Thomas Joris, Jana Haddow, Graham P Taylor, et al.
Blood|September 8, 2012
HTLV-1-infected T cells contain a single integrated provirus in natural infectionLucy B Cook, Aileen G Rowan, Anat Melamed, et al.
Frontiers in Immunology|March 20, 2023
CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphomaAileen G Rowan, Kanagaraju Ponnusamy, Hongwei Ren, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Blood|April 24, 2020
CD28 fusions: an opportunity for young ATL?Lucy B M Cook, Aileen G Rowan
Leukemia Research and Treatment|December 22, 2012
Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?Aileen G Rowan, Charles R M Bangham
Leukemia Research|December 6, 2024
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)Devon A Weterings, Aileen G Rowan, Lucy B Cook
Virology|December 11, 2012
HTLV-1: persistence and pathogenesisLucy B Cook, Marjet Elemans, Aileen G Rowan, et al.
Blood|February 9, 2011
The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signalsAndrea K Kress, Martina Kalmer, Aileen G Rowan, et al.
European Journal of Immunology|November 25, 2003
Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytesMiriam T Brady, Angus J MacDonald, Aileen G Rowan, et al.
Plos Pathogens|April 23, 2016
CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines Their Susceptibility to CTL-Mediated LysisKiruthika Manivannan, Aileen G Rowan, Yuetsu Tanaka, et al.
Frontiers in Immunology|April 28, 2023
Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?Thomas Joris, Jana Haddow, Graham P Taylor, et al.
Blood|September 8, 2012
HTLV-1-infected T cells contain a single integrated provirus in natural infectionLucy B Cook, Aileen G Rowan, Anat Melamed, et al.
Frontiers in Immunology|March 20, 2023
CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphomaAileen G Rowan, Kanagaraju Ponnusamy, Hongwei Ren, et al.
Pageof 3